Orforglipron, Placebo to match LY, Orforglipron, Orforglipron, Orforglipron, Orforglipron, Orforglipron
J2A-MC-GZPO
Phase 3 small_molecule active
Quick answer
Orforglipron, Placebo to match LY, Orforglipron, Orforglipron, Orforglipron, Orforglipron, Orforglipron for GZP1, GZP2: Obesity, Overweight GZP2: Type 2 Diabetes is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- GZP1, GZP2: Obesity, Overweight GZP2: Type 2 Diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active